Cargando…
Radiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part II
PURPOSE: To assess the influence of the radiobiological doses, tumor, and treatment features on retinopathy, cataracts, retinal detachment, optic neuropathy, vitreous hemorrhage, and neovascular glaucoma at the authors’ institution after brachytherapy for posterior uveal melanoma. MATERIAL AND METHO...
Autores principales: | Miguel, David, de Frutos-Baraja, Jesús María, López-Lara, Francisco, Saornil, María Antonia, García-Álvarez, Ciro, Alonso, Pilar, Diezhandino, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142647/ https://www.ncbi.nlm.nih.gov/pubmed/30237818 http://dx.doi.org/10.5114/jcb.2018.77955 |
Ejemplares similares
-
Radiobiological doses, tumor, and treatment features influence on local control, enucleation rates, and survival after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part I
por: Miguel, David, et al.
Publicado: (2018) -
Visual outcome after posterior uveal melanoma episcleral brachytherapy including radiobiological doses
por: Miguel, David, et al.
Publicado: (2018) -
Treatment planning considerations for (125)I eye plaque brachytherapy
por: Miguel, David, et al.
Publicado: (2019) -
Bilateral episcleral brachytherapy in simultaneous choroidal melanoma and circumscribed hemangioma
por: Correa-Pérez, María Encarnación, et al.
Publicado: (2013) -
A study comparing baseline and best-corrected visual acuity after iodine-125 episcleral brachytherapy in uveal melanoma
por: Miguel, David, et al.
Publicado: (2023)